slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 67,681-67,710
Pages 3,679
Rows per page 30
Component
67,681-67,710 of 110,355
09
The table provides a reconciliation of GAAP to Non-GAAP operating expenses, highlighting the impact of stock-based compensation, restructuring, and legal/transaction costs.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Need1 hit
11
The table provides year-over-year and quarter-over-quarter percentage changes for inventory categories.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations 1 hit
14
LSD = low single digits, LDD = low double digitsSonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
15
The slide uses a bar chart to show historical margin performance and a future guidance point.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Satisfaction1 hit
24
The slide highlights market leadership across specific product categories ($200+ Home Theater and $150+ All In One) in two major regions.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
26
The chart uses a combination of a line graph for applications and a bar chart for issued patents.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
28
The slide uses a custom flywheel-style diagram to illustrate the relationship between growth drivers and market conditions.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
30
Uses a nested circle diagram to illustrate market segmentation and penetration.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
33
Uses a nested circle diagram to show market segmentation and penetration.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
35
The slide highlights a strategic shift toward higher-margin channels (DTC and IS) which now account for 44% of total revenue.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
40
Note: $ in thousands, unaudited.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
12
The slide serves as a disclosure of the underlying logic for a hypothetical financial scenario.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Resolution1 hit
03
The slide uses three distinct bar charts to compare year-over-year performance.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · Attention1 hit
05
Revenue chart is a stacked bar chart; Gross Profit chart is a combo chart with bars for profit and dots for margin percentage.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
06
Operating Expenses chart is a stacked bar chart showing OpEx vs SBC + Non-Recurring expenses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
The advertising spend chart shows percentage decreases quarter-over-quarter.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
Includes a screenshot of a BMC Neurology paper and a bar chart showing subgroup analysis of OHSA scores.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a biological process diagram to explain how different drugs (agonists, precursors, reuptake inhibitors) affect sympathetic signaling to blood vessels.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a biological process diagram to explain the drug's mechanism of action.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
11
The slide uses a process flow diagram to show how patients transition from Study 0169 to 0170.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
14
The chart illustrates a worsening of blood pressure in the placebo group compared to the treatment group.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
15
The slide uses a bar chart with error bars to show treatment effects. 'Worsening' is indicated by a downward arrow on the right.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
17
Poster #106Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
25
Uses a visual comparison to explain the biological mechanism of action.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
28
The slide includes a table of adverse events and bulleted takeaways regarding clinical safety parameters.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
30
Poster #4Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
32
The slide uses a bulleted list to frame the clinical trial narrative from failure to a focused subgroup opportunity.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
33
The slide uses a biological mechanism diagram to illustrate the drug's effect on norepinephrine reuptake.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
37
The slide provides a summary of patient characteristics to demonstrate baseline comparability.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
38
The chart uses a split-axis design to represent different study periods (Study 0169 and 0170).Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit